S&P 500 Futures
(-0.19%) 5 204.00 points
Dow Jones Futures
(-0.08%) 38 997 points
Nasdaq Futures
(-0.25%) 18 154 points
Oil
(-1.17%) $77.46
Gas
(2.72%) $2.27
Gold
(0.03%) $2 324.90
Silver
(-0.09%) $27.52
Platinum
(-0.71%) $981.40
USD/EUR
(0.11%) $0.931
USD/NOK
(0.25%) $10.93
USD/GBP
(0.18%) $0.801
USD/RUB
(0.52%) $91.92

リアルタイムの更新: Sanofi India Limited [SANOFI.NS]

取引所: NSE セクター: Healthcare 産業: Drug Manufacturers—General
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-10)

Expected move: +/- 2.40%

最終更新日時8 5月 2024 @ 19:00

-1.52% INR 8 246.25

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 19:00):

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors...

Stats
本日の出来高 9 345.00
平均出来高 19 219.00
時価総額 189.91B
EPS INR0 ( 2024-02-23 )
次の収益日 ( INR0 ) 2024-05-10
Last Dividend INR183.00 ( 2023-04-28 )
Next Dividend INR0 ( N/A )
P/E 31.46
ATR14 INR7.09 (0.09%)

ボリューム 相関

長: -0.25 (neutral)
短: -0.11 (neutral)
Signal:(55.979) Neutral

Sanofi India Limited 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Sanofi India Limited 相関 - 通貨/商品

The country flag 0.19
( neutral )
The country flag 0.21
( neutral )
The country flag 0.32
( neutral )
The country flag 0.20
( neutral )
The country flag 0.31
( neutral )
The country flag -0.23
( neutral )

Sanofi India Limited 財務諸表

Annual 2023
収益: INR28.51B
総利益: INR12.40B (43.49 %)
EPS: INR261.78
FY 2023
収益: INR28.51B
総利益: INR12.40B (43.49 %)
EPS: INR261.78
FY 2022
収益: INR27.70B
総利益: INR15.81B (57.06 %)
EPS: INR269.47
FY 2021
収益: INR29.57B
総利益: INR16.50B (55.80 %)
EPS: INR410.06

Financial Reports:

No articles found.

Sanofi India Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR193.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR183.00
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Sanofi India Limited Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.09 - Stable (18.28%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR13.50 2003-05-30
Last Dividend INR183.00 2023-04-28
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 39 --
Total Paid Out INR1 983.50 --
Avg. Dividend % Per Year 2.98% --
Score 4.36 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.09
Div. Directional Score 7.59 --
Next Divdend (Est)
(2024-10-07)
INR189.96 Estimate 3.64 %
Dividend Stability
0.29 Very Poor
Dividend Score
4.36
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2003 INR0 0.00%
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR71.00 1.47%
2019 INR66.00 1.04%
2020 INR486.00 6.93%
2021 INR240.00 2.90%
2022 INR502.00 6.45%
2023 INR183.00 3.14%
2024 INR0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
HBSL.NS Dividend Junior 2023-08-11 Sporadic 12 0.78%
BEPL.NS Dividend King 2023-07-25 Semi-Annually 20 4.91%
RADICO.NS Dividend Junior 2023-09-14 Annually 22 0.24%
KHAICHEM.NS No Dividend Player 2023-07-21 Annually 5 0.32%
EMAMIPAP.NS Dividend Junior 2023-09-05 Annually 3 0.56%
AJANTPHARM.NS Dividend Knight 2023-08-04 Annually 23 0.57%
SUNTV.NS Dividend Knight 2023-08-22 Quarterly 19 1.94%
NAVNETEDUL.NS Dividend Junior 2023-08-07 Annually 22 1.10%
HPIL.NS Dividend Junior 2023-09-29 Annually 5 0.89%
CARERATING.NS Dividend Knight 2023-07-06 Semi-Annually 12 1.81%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2111.5005.778.66[0 - 0.5]
returnOnAssetsTTM0.3521.20010.0010.00[0 - 0.3]
returnOnEquityTTM0.6451.5003.955.92[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.9160.8005.424.34[1 - 3]
quickRatioTTM0.8600.8009.657.72[0.8 - 2.5]
cashRatioTTM0.6241.5007.6410.00[0.2 - 2]
debtRatioTTM0.0111-1.5009.82-10.00[0 - 0.6]
interestCoverageTTM480.821.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM25.532.001.4902.98[0 - 30]
freeCashFlowPerShareTTM25.532.0010.0010.00[0 - 20]
debtEquityRatioTTM0.0187-1.5009.93-10.00[0 - 2.5]
grossProfitMarginTTM0.5431.0004.284.28[0.2 - 0.8]
operatingProfitMarginTTM0.2871.0006.276.27[0.1 - 0.6]
cashFlowToDebtRatioTTM3.091.00010.0010.00[0.2 - 2]
assetTurnoverTTM1.6630.8002.251.799[0.5 - 2]
Total Score11.10

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM31.841.0006.890[1 - 100]
returnOnEquityTTM0.6452.506.115.92[0.1 - 1.5]
freeCashFlowPerShareTTM25.532.001.49010.00[0 - 30]
dividendYielPercentageTTM2.001.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM25.532.001.4902.98[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM2.111.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.02061.000-1.9840[0.1 - 0.5]
Total Score4.09

Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。